| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.53B | +18.3% |
| Cost of Revenue | $545.6M | -7.0% |
| Gross Profit | $988.3M | +39.3% |
| R&D Expense | $168.1M | +116.3% |
| SG&A Expense | $193.7M | +54.4% |
| Operating Income | $457.0M | +25.3% |
| Pre-tax Income | $431.0M | +4.9% |
| Income Tax | $118.5M | +40.6% |
| Net Income | $312.4M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $912.8M | +27.9% |
| Accounts Receivable | $321.3M | +13.0% |
| Inventory | $68.0M | +6.2% |
| Current Assets | $1.33B | +22.2% |
| Total Assets | $1.98B | +19.9% |
| Current Liabilities | $240.5M | +28.4% |
| Long-term Debt | $565.3M | +0.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $544.8M | +78.5% |
| Capital Expenditures | $51.6M | +10.9% |
| Investing Cash Flow | -$226.0M | -3905.6% |
| Financing Cash Flow | -$118.5M | -807.5% |
| Free Cash Flow | $493.1M | +90.6% |
| -4.4% |
| EPS (Basic) | $4.52 | -5.6% |
| EPS (Diluted) | $4.36 | -6.2% |
| Total Liabilities |
| $892.3M |
| +6.8% |
| Stockholders' Equity | $1.09B | +33.4% |